364 related articles for article (PubMed ID: 26290039)
1. Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells.
Shoji E; Sakurai H; Nishino T; Nakahata T; Heike T; Awaya T; Fujii N; Manabe Y; Matsuo M; Sehara-Fujisawa A
Sci Rep; 2015 Aug; 5():12831. PubMed ID: 26290039
[TBL] [Abstract][Full Text] [Related]
2. Dantrolene enhances antisense-mediated exon skipping in human and mouse models of Duchenne muscular dystrophy.
Kendall GC; Mokhonova EI; Moran M; Sejbuk NE; Wang DW; Silva O; Wang RT; Martinez L; Lu QL; Damoiseaux R; Spencer MJ; Nelson SF; Miceli MC
Sci Transl Med; 2012 Dec; 4(164):164ra160. PubMed ID: 23241744
[TBL] [Abstract][Full Text] [Related]
3. A muscle fatigue-like contractile decline was recapitulated using skeletal myotubes from Duchenne muscular dystrophy patient-derived iPSCs.
Uchimura T; Asano T; Nakata T; Hotta A; Sakurai H
Cell Rep Med; 2021 Jun; 2(6):100298. PubMed ID: 34195678
[TBL] [Abstract][Full Text] [Related]
4. Acute conversion of patient-derived Duchenne muscular dystrophy iPSC into myotubes reveals constitutive and inducible over-activation of TGFβ-dependent pro-fibrotic signaling.
Caputo L; Granados A; Lenzi J; Rosa A; Ait-Si-Ali S; Puri PL; Albini S
Skelet Muscle; 2020 May; 10(1):13. PubMed ID: 32359374
[TBL] [Abstract][Full Text] [Related]
5. Prednisolone rescues Duchenne muscular dystrophy phenotypes in human pluripotent stem cell-derived skeletal muscle in vitro.
Al Tanoury Z; Zimmerman JF; Rao J; Sieiro D; McNamara HM; Cherrier T; Rodríguez-delaRosa A; Hick-Colin A; Bousson F; Fugier-Schmucker C; Marchiano F; Habermann B; Chal J; Nesmith AP; Gapon S; Wagner E; Gupta VA; Bassel-Duby R; Olson EN; Cohen AE; Parker KK; Pourquié O
Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34260377
[TBL] [Abstract][Full Text] [Related]
6. Antisense PMO cocktails effectively skip dystrophin exons 45-55 in myotubes transdifferentiated from DMD patient fibroblasts.
Lee J; Echigoya Y; Duddy W; Saito T; Aoki Y; Takeda S; Yokota T
PLoS One; 2018; 13(5):e0197084. PubMed ID: 29771942
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of intracellular Ca
Sato M; Shiba N; Miyazaki D; Shiba Y; Echigoya Y; Yokota T; Takizawa H; Aoki Y; Takeda S; Nakamura A
Biochem Biophys Res Commun; 2019 Nov; 520(1):179-185. PubMed ID: 31585729
[TBL] [Abstract][Full Text] [Related]
8. Nanotopography-responsive myotube alignment and orientation as a sensitive phenotypic biomarker for Duchenne Muscular Dystrophy.
Xu B; Magli A; Anugrah Y; Koester SJ; Perlingeiro RCR; Shen W
Biomaterials; 2018 Nov; 183():54-66. PubMed ID: 30149230
[TBL] [Abstract][Full Text] [Related]
9. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.
Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N
Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519
[TBL] [Abstract][Full Text] [Related]
10. The intracellular Ca2+ concentration is elevated in cardiomyocytes differentiated from hiPSCs derived from a Duchenne muscular dystrophy patient.
Tsurumi F; Baba S; Yoshinaga D; Umeda K; Hirata T; Takita J; Heike T
PLoS One; 2019; 14(3):e0213768. PubMed ID: 30875388
[TBL] [Abstract][Full Text] [Related]
11. Duchenne Muscular Dystrophy Myogenic Cells from Urine-Derived Stem Cells Recapitulate the Dystrophin Genotype and Phenotype.
Falzarano MS; D'Amario D; Siracusano A; Massetti M; Amodeo A; La Neve F; Maroni CR; Mercuri E; Osman H; Scotton C; Armaroli A; Rossi R; Selvatici R; Crea F; Ferlini A
Hum Gene Ther; 2016 Oct; 27(10):772-783. PubMed ID: 27530229
[TBL] [Abstract][Full Text] [Related]
12. A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells.
Young CS; Hicks MR; Ermolova NV; Nakano H; Jan M; Younesi S; Karumbayaram S; Kumagai-Cresse C; Wang D; Zack JA; Kohn DB; Nakano A; Nelson SF; Miceli MC; Spencer MJ; Pyle AD
Cell Stem Cell; 2016 Apr; 18(4):533-40. PubMed ID: 26877224
[TBL] [Abstract][Full Text] [Related]
13. Contractile Activity of Myotubes Derived from Human Induced Pluripotent Stem Cells: A Model of Duchenne Muscular Dystrophy.
Yoshioka K; Ito A; Horie M; Ikeda K; Kataoka S; Sato K; Yoshigai T; Sakurai H; Hotta A; Kawabe Y; Kamihira M
Cells; 2021 Sep; 10(10):. PubMed ID: 34685536
[TBL] [Abstract][Full Text] [Related]
14. De novo revertant fiber formation and therapy testing in a 3D culture model of Duchenne muscular dystrophy skeletal muscle.
Ebrahimi M; Lad H; Fusto A; Tiper Y; Datye A; Nguyen CT; Jacques E; Moyle LA; Nguyen T; Musgrave B; Chávez-Madero C; Bigot A; Chen C; Turner S; Stewart BA; Pegoraro E; Vitiello L; Gilbert PM
Acta Biomater; 2021 Sep; 132():227-244. PubMed ID: 34048976
[TBL] [Abstract][Full Text] [Related]
15. Chimeric RNA/ethylene-bridged nucleic acids promote dystrophin expression in myocytes of duchenne muscular dystrophy by inducing skipping of the nonsense mutation-encoding exon.
Surono A; Van Khanh T; Takeshima Y; Wada H; Yagi M; Takagi M; Koizumi M; Matsuo M
Hum Gene Ther; 2004 Aug; 15(8):749-57. PubMed ID: 15319032
[TBL] [Abstract][Full Text] [Related]
16. Immortalized skin fibroblasts expressing conditional MyoD as a renewable and reliable source of converted human muscle cells to assess therapeutic strategies for muscular dystrophies: validation of an exon-skipping approach to restore dystrophin in Duchenne muscular dystrophy cells.
Chaouch S; Mouly V; Goyenvalle A; Vulin A; Mamchaoui K; Negroni E; Di Santo J; Butler-Browne G; Torrente Y; Garcia L; Furling D
Hum Gene Ther; 2009 Jul; 20(7):784-90. PubMed ID: 19358679
[TBL] [Abstract][Full Text] [Related]
17. Concordant but Varied Phenotypes among Duchenne Muscular Dystrophy Patient-Specific Myoblasts Derived using a Human iPSC-Based Model.
Choi IY; Lim H; Estrellas K; Mula J; Cohen TV; Zhang Y; Donnelly CJ; Richard JP; Kim YJ; Kim H; Kazuki Y; Oshimura M; Li HL; Hotta A; Rothstein J; Maragakis N; Wagner KR; Lee G
Cell Rep; 2016 Jun; 15(10):2301-2312. PubMed ID: 27239027
[TBL] [Abstract][Full Text] [Related]
18. Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy.
Lin B; Li Y; Han L; Kaplan AD; Ao Y; Kalra S; Bett GC; Rasmusson RL; Denning C; Yang L
Dis Model Mech; 2015 May; 8(5):457-66. PubMed ID: 25791035
[TBL] [Abstract][Full Text] [Related]
19. Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy.
He R; Li H; Wang L; Li Y; Zhang Y; Chen M; Zhu Y; Zhang C
Biol Res; 2020 May; 53(1):22. PubMed ID: 32430065
[TBL] [Abstract][Full Text] [Related]
20. A Novel CRISPR-Cas9 Strategy to Target DYSTROPHIN Mutations Downstream of Exon 44 in Patient-Specific DMD iPSCs.
Dhoke NR; Kim H; Azzag K; Crist SB; Kiley J; Perlingeiro RCR
Cells; 2024 Jun; 13(11):. PubMed ID: 38891104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
